0000950170-24-073235.txt : 20240613 0000950170-24-073235.hdr.sgml : 20240613 20240613191434 ACCESSION NUMBER: 0000950170-24-073235 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240605 FILED AS OF DATE: 20240613 DATE AS OF CHANGE: 20240613 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ros Matthew CENTRAL INDEX KEY: 0001673802 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38443 FILM NUMBER: 241042653 MAIL ADDRESS: STREET 1: C/O EPIZYME, INC. STREET 2: 400 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cogent Biosciences, Inc. CENTRAL INDEX KEY: 0001622229 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 465308248 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 275 WYMAN STREET STREET 2: 3RD FLOOR CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-945-5576 MAIL ADDRESS: STREET 1: 275 WYMAN STREET STREET 2: 3RD FLOOR CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: Unum Therapeutics Inc. DATE OF NAME CHANGE: 20180402 FORMER COMPANY: FORMER CONFORMED NAME: Unum Therapeutics, Inc. DATE OF NAME CHANGE: 20141014 4 1 ownership.xml 4 X0508 4 2024-06-05 0001622229 Cogent Biosciences, Inc. COGT 0001673802 Ros Matthew C/O COGENT BIOSCIENCES, INC. 275 WYMAN STREET, 3RD FLOOR WALTHAM MA 02451 true false false false false Stock Option (Right to Buy) 8.92 2024-06-05 4 A false 44700 0.00 A 2034-06-05 Common Stock 44700 44700 D This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2025 Annual Meeting of Stockholders. /s/ Evan D. Kearns, Attorney-in-Fact 2024-06-13